-
AstraZenecon has submitted a clinical application for a new generation of oral estrogen-influenced antagonists
Time of Update: 2021-01-15
AZD9833 belongs to a new generation of oral selective estrogen inhibitors (ER alpha) antagonists and degradation agents (SERDs).
-
Technology: Pioneering new technologies for exhaling detection and exploring new opportunities for the diagnosis of infectious diseases and tumors
Time of Update: 2021-01-15
of auxiliary means, for hospitals, scientific research institutions, third-party testing centers and other institutions to provide a new non-invasive, accurate, convenient, low-cost screening and identification diagnostic solutions. keenly aware
-
Weekend Talk: New Crown Vaccines and Anti-Immunity (sterilizing immunity)
Time of Update: 2021-01-15
that mean that the new crown vaccine is a "selfish" vaccine for people who only have it, regardless of others? If it is still contagious, the health code will still not turn green, travel also need to do nucleic acid or antibody testing, the benefits
-
PNAS: Scientists have published a molecular mechanism of stevia sugar that could be used in new calorie-free sweeteners
Time of Update: 2021-01-15
" is unique to the main molecules in plant leaves, namely stevia and RebA, whose chemical structure touches the taste-like subjects on the tongue, triggering sweetness, but they also touch the taste-like bodies that trigger other flavors.
-
Zhejiang Provincial Market Supervision Administration Food Safety Supervision and Sampling Information Notice - New Year's Day Special (No. 51 of 2020)
Time of Update: 2021-01-15
institution is Zhejiang Fangyuan Inspection Group Co., Ltd. (viii) Xuzhou Rui good education consulting Co. , Ltd. in Tmall (online shop) sales of the label Haining City Red Friends Food Co. , Ltd. production of cassava starch, the total number
-
U.S. media: Up to 59% of new coronavirus transmission in the United States is caused by asymptomatic infections
Time of Update: 2021-01-15
Up to 59 percent of new coronavirus transmission in the U.S. is caused by asymptomatic infections, according to the latest model developed by CDC researchers, USA Today reported on January 8.
-
The Drug Administration has approved the new coronary vaccine Phase II clinical, with BioNTech supplying at least 100 million doses next year
Time of Update: 2021-01-15
BioNTech is committed to supplying Chinese mainland 100 million doses of new crown vaccine products to the united States by 2021.
-
British companies have developed new heat-resistant metal coatings for the new aircraft carrier deck
Time of Update: 2021-01-15
companies have developed a new heat-resistant metal coating that can be used on the flight deck of the Queen Elizabeth-class aircraft carrier.
-
What does it mean that the new crown vaccine is 79.34% effective? Can I fight between the ages of 3 and 17?
Time of Update: 2021-01-15
. how long will the new crown vaccine be protected? Really not more than half a year? On the issue of public concern, Zhang Yuntao said it was too early to define a vaccine protection time because the new coronavirus discovery and clinical
-
Nat Commun: Wuhan University and other multi-unit cooperation! Zhongbo/Lindandan/Yuan reveals new
Time of Update: 2021-01-15
CCL7 showed high expression in NSCLC tumor tissue and was positively related to the immersion of cDC1 in TME and the overall survival of NSCLC patients.
-
The domestic listing application for the new crown vaccine of The Chinese medicine was accepted, and the Phase III clinical treatment continued
Time of Update: 2021-01-15
health supervision authority in Bahrain on the 13th of this month, officially approved The Chinese National Pharmaceutical Group developed a new crown inactivated vaccine registered in Bahrain.
-
"IPO New Year" capital continues to contribute to innovative research and development 2020 Bio-industry listing summary
Time of Update: 2021-01-15
show that the board's preference for IVD enterprises concentrated in POCT, chemical luminescence, PCR molecular diagnosis and other fields, declared enterprises characterized by average income of more than 200 million yuan, net profit of more than 40
-
Guidelines for clinical application of new anti-tumor drugs (2020 edition), covering 9 major cancerous tumors and 83 drugs
Time of Update: 2021-01-15
In order to further standardize the clinical application of new anti-tumor drugs, improve the level of rational use of cancer drugs, ensure the quality of medical care and medical safety, and safeguard the health rights and interests of cancer
-
The Pfizer/BioNTech vaccine is protective against the new coronavirus mutation
Time of Update: 2021-01-15
strain (N501) used to develop BNT162b2, resulting in a new strain (Y501) that replaced the original coronary strain with tyrosine (Y) in addition to the amino acid in the 501st bit of the hedgehog protein. a diagram of the Y501 strain (photo
-
Blood: TLR9, a new potential therapeutic target for chronic lymphocytic leukemia!
Time of Update: 2021-01-15
addition, elevated levels of free DNA were associated with a reduction in the time from the first treatment (TTFT: p=0.003, HR=4.0).
-
And Platinum Pharmaceuticals jointly announced the launch of AbbVie's new Coronary Antibody Phase 1 clinical trial
Time of Update: 2021-01-15
Phase I clinical trials will be a randomized, double-blind, placebo-controlled study designed to assess the safety, pharmacodynamics, and pharmacodynamics of ABBV-47D11 in a single dose climb in COVID-19 adult hospitalized populations.
-
AstraZeneia PARP inhibitors are to be included in the priority review and two new drugs have been approved clinically
Time of Update: 2021-01-15
, and the first approved PARP inhibitor. target DNA damage repair response (DDR) path, using the principle of "synthetic death" to kill cancer cells without affecting healthy cells. the drug was first approved in the U.S. in December 2014 to treat
-
Signal Transduct Target Ther: The team of Cai Xiujun of Zhejiang University has revealed new
Time of Update: 2021-01-15
Hepatocellular carcinoma (HCC) is the most common primary liver cancer, with the sixth highest incidence of malignant tumors and the fourth highest fatality rate among tumor-related causes of death worldwide. For advanced liver cancer
-
cancer after a new line of assisted chemotherapy with carptin-yew alcohol
Time of Update: 2021-01-15
diagnosed FIGO phased IC-I with ECOG performance status of 0-2 points and life expectancy of 12 weeks Patients with high-level slurry, transparent cells, or any lowly differentiated, or histological stage 3/FIGO IIB-IV ovaries, fallopian tubes
-
National Science Review: Breakthroughs . . The new strategy proposed by Liu Hongke/Zhao Jin/Guo
Time of Update: 2021-01-15
with bioactive molecules when it enters the body. strategy of "bio orthotic catalytic death" provides a new approach and platform for drug development for precise and efficient treatment of diseases. cancer is one of the most serious diseases
